Indo US Bio-Tech Ltd
Incorporated in 2004, Indo US Bio-Tech Ltd is engaged in production and processing of commercial and vegetable seeds[1]
- Market Cap ₹ 133 Cr.
- Current Price ₹ 66.6
- High / Low ₹ 159 / 57.5
- Stock P/E 30.8
- Book Value ₹ 45.8
- Dividend Yield 0.00 %
- ROCE 14.5 %
- ROE 15.3 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 64.6 to 45.5 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.58 | 19.02 | 24.26 | 29.40 | 35.35 | 39.76 | 39.37 | 49.38 | 60.84 | 72.84 | 103.84 | 110.44 | 96.86 | |
| Sales growth | +32.75% | -2.86% | +27.55% | +21.19% | +20.24% | +12.48% | -0.98% | +25.43% | +23.21% | +19.72% | +42.56% | +6.36% | -18.30% |
| 18.98 | 18.52 | 23.02 | 26.69 | 31.91 | 35.78 | 33.83 | 42.43 | 51.45 | 62.05 | 84.90 | 93.43 | 88.12 | |
| Operating Profit | 0.60 | 0.50 | 1.24 | 2.71 | 3.44 | 3.98 | 5.54 | 6.95 | 9.39 | 10.79 | 18.94 | 17.01 | 8.74 |
| OPM % | 3.06% | 2.63% | 5.11% | 9.22% | 9.73% | 10.01% | 14.07% | 14.07% | 15.43% | 14.81% | 18.24% | 15.40% | 9.02% |
| 0.09 | 0.10 | 0.07 | 0.22 | 0.03 | -0.01 | 0.03 | 0.18 | 0.02 | 0.32 | 0.18 | 0.05 | 0.20 | |
| Interest | 0.32 | 0.22 | 0.64 | 0.72 | 0.40 | 0.88 | 1.18 | 1.20 | 1.20 | 1.52 | 1.49 | 2.24 | 2.92 |
| Depreciation | 0.11 | 0.14 | 0.15 | 0.17 | 0.25 | 0.23 | 0.26 | 0.44 | 0.83 | 0.80 | 1.10 | 0.90 | 1.04 |
| Profit before tax | 0.26 | 0.24 | 0.52 | 2.04 | 2.82 | 2.86 | 4.13 | 5.49 | 7.38 | 8.79 | 16.53 | 13.92 | 4.98 |
| Tax % | -92.31% | -50.00% | 25.00% | 28.92% | 25.53% | 11.54% | -23.49% | 4.55% | 2.03% | 6.37% | 1.57% | 5.75% | |
| 0.50 | 0.36 | 0.40 | 1.45 | 2.09 | 2.53 | 5.10 | 5.24 | 7.24 | 8.24 | 16.27 | 13.12 | 4.34 | |
| EPS in Rs | 0.48 | 0.35 | 0.38 | 1.41 | 1.44 | 1.74 | 3.52 | 2.86 | 3.60 | 4.11 | 8.11 | 6.54 | 2.17 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 23% |
| 3 Years: | 22% |
| TTM: | -18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 43% |
| 5 Years: | 21% |
| 3 Years: | 22% |
| TTM: | -74% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 13% |
| 3 Years: | -31% |
| 1 Year: | -50% |
| Return on Equity | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 17% |
| 3 Years: | 18% |
| Last Year: | 15% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.49 | 1.49 | 1.49 | 3.42 | 4.85 | 6.07 | 6.07 | 9.17 | 10.03 | 20.05 | 20.05 | 20.05 | 20.05 |
| Reserves | 1.41 | 1.77 | 2.00 | 1.52 | 9.05 | 10.37 | 15.47 | 29.71 | 44.47 | 42.70 | 58.47 | 72.48 | 71.85 |
| 1.69 | 4.68 | 4.85 | 6.54 | 6.17 | 8.58 | 11.48 | 12.50 | 11.60 | 14.33 | 14.84 | 37.03 | 44.17 | |
| 3.09 | 5.74 | 4.20 | 5.67 | 3.81 | 9.68 | 10.66 | 4.19 | 3.37 | 7.38 | 4.49 | 3.54 | 4.26 | |
| Total Liabilities | 7.68 | 13.68 | 12.54 | 17.15 | 23.88 | 34.70 | 43.68 | 55.57 | 69.47 | 84.46 | 97.85 | 133.10 | 140.33 |
| 1.09 | 1.06 | 1.21 | 1.50 | 1.37 | 1.41 | 2.33 | 5.54 | 7.37 | 6.69 | 10.23 | 11.22 | 11.19 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 1.17 | 1.28 | 1.99 | 2.32 | 1.37 | 3.78 | 0.00 | 0.50 | 1.03 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 6.59 | 12.62 | 11.33 | 15.65 | 21.34 | 32.01 | 39.35 | 47.70 | 60.73 | 73.99 | 87.62 | 121.38 | 128.11 | |
| Total Assets | 7.68 | 13.68 | 12.54 | 17.15 | 23.88 | 34.70 | 43.68 | 55.57 | 69.47 | 84.46 | 97.85 | 133.10 | 140.33 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.07 | -0.88 | -3.17 | -0.84 | 0.22 | 2.91 | 0.53 | 2.22 | 1.42 | -12.58 | |||
| -0.17 | 0.31 | -2.56 | -0.57 | -1.75 | -5.40 | -6.67 | -2.53 | -0.79 | -1.50 | |||
| 0.05 | 0.59 | 5.74 | 1.53 | 1.46 | 2.41 | 6.29 | 1.22 | -1.48 | 19.96 | |||
| Net Cash Flow | -0.05 | 0.02 | 0.01 | 0.12 | -0.07 | -0.08 | 0.14 | 0.91 | -0.85 | 5.88 | ||
| Free Cash Flow | -0.10 | -1.33 | -4.46 | -1.21 | -1.68 | -1.06 | -1.29 | -0.39 | 0.56 | -14.99 | ||
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 11% | -16% | -92% | -20% | 6% | 47% | 9% | 23% | 9% | -71% |
Ratios
Standalone / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 24.61 | 107.27 | 76.13 | 111.61 | 93.55 | 192.60 | 228.90 | 151.82 | 148.42 | 95.46 | 52.73 | 45.48 |
| Inventory Days | 90.92 | 117.84 | 92.15 | 98.01 | 176.09 | 750.51 | ||||||
| Days Payable | 56.63 | 115.41 | 64.13 | 71.45 | 33.87 | 666.84 | ||||||
| Cash Conversion Cycle | 58.89 | 109.70 | 104.15 | 138.17 | 235.77 | 276.26 | 228.90 | 151.82 | 148.42 | 95.46 | 52.73 | 45.48 |
| Working Capital Days | 66.36 | 32.62 | 33.55 | 59.34 | 128.55 | 137.43 | 185.79 | 257.23 | 284.55 | 266.23 | 246.51 | 248.04 |
| ROCE % | 13.94% | 7.34% | 14.25% | 27.85% | 20.41% | 16.68% | 18.33% | 15.85% | 14.61% | 14.40% | 21.15% | 14.50% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| R&D expenditure Rs. |
|
|||||||||
| Number of dealers/distributors count |
||||||||||
| Number of states with distribution network count |
||||||||||
| Agricultural Activities share of segment revenue % |
||||||||||
| Number of employees count |
||||||||||
| Storage capacity (godown + cold storage) tonnes |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Publication Unaudited Financial Results for the quarter ended on 30-09-2026.
- Results- Financial Results For September 30, 2026
-
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, October 30, 2026, Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
- Board approved unaudited results for quarter/half-year ended 30 September 2026.
-
Board Meeting Intimation for Considering, Approving And Take On Record The Un-Audited Standalone Financial Result Of The Company For The Quarter And Half Year Ended 30Th September, 2026.
- Board meeting on 30 Oct 2026 to consider Q2 and half-year unaudited standalone financial results.
-
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 Regarding Directors Cum Promoters And Other Promoter Visit To China.
- Promoters invited to attend the 140th Canton Fair in Guangzhou, China.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
Business Overview:[1]
IUBTL is involved in crop Research and Development through breeding, seed production, processing, packing, and marketing of hybrid and open pollinated varieties of agricultural crops